用户名: 密码: 验证码:
Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis
详细信息    查看全文
  • 作者:Yong Liao ; Jian-Lin Huang ; Ming-Xing Qiu ; Zhi-Wei Ma
  • 关键词:Bladder cancer ; Vitamin D ; Risk ; Meta ; analysis
  • 刊名:Tumor Biology
  • 出版年:2015
  • 出版时间:March 2015
  • 年:2015
  • 卷:36
  • 期:3
  • 页码:1567-1572
  • 全文大小:255 KB
  • 参考文献:1. Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, et al. Summary of the 8th annual bladder cancer think tank: collaborating to move research forward. Urol Oncol. 2014.
    2. Jemal, A, Siegel, R, Xu, J, Ward, E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: pp. 277-300 CrossRef
    3. Keimling, M, Behrens, G, Schmid, D, Jochem, C, Leitzmann, MF (2014) The association between physical activity and bladder cancer: systematic review and meta-analysis. Br J Cancer 110: pp. 1862-70 CrossRef
    4. Mohr, SB, Garland, CF, Gorham, ED, Grant, WB, Garland, FC (2010) Ultraviolet b irradiance and incidence rates of bladder cancer in 174 countries. Am J Prev Med 38: pp. 296-302 CrossRef
    5. Kaufman, DS, Shipley, WU, Feldman, AS (2009) Bladder cancer. Lancet 374: pp. 239-49 CrossRef
    6. Albert, PJ, Proal, AD, Marshall, TG (2009) Vitamin D: the alternative hypothesis. Autoimmun Rev 8: pp. 639-44 CrossRef
    7. Dixon, KM, Mason, RS (2009) Vitamin D. Int J Biochem Cell Biol 41: pp. 982-5 CrossRef
    8. Plum, LA, DeLuca, HF (2010) Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9: pp. 941-55 CrossRef
    9. Mora, JR, Iwata, M, Andrian, UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8: pp. 685-98 CrossRef
    10. Bikle, D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94: pp. 26-34 CrossRef
    11. Bischoff-Ferrari, HA (2014) Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 810: pp. 500-25
    12. Ordonez Mena, JM, Brenner, H (2014) Vitamin D and cancer: an overview on epidemiological studies. Adv Exp Med Biol 810: pp. 17-32
    13. Lee, JE, Li, H, Chan, AT (2011) Circulating levels of vitamin D and colon and rectal cancer: the physicians-health study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 4: pp. 735-43 CrossRef
    14. Ordonez-Mena, JM, Schottker, B, Haug, U (2013) Serum 25-hydroxyvitamin D and cancer risk in older adults: results from a large German prospective cohort study. Cancer Epidemiol Biomarkers Prev 22: pp. 905-16 CrossRef
    15. Kim, Y, Je, Y (2014) Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer 110: pp. 2772-84 CrossRef
    16. Giovannucci, E, Liu, Y, Rimm, EB (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98: pp. 451-9 CrossRef
    17. Amaral, AF, Mendez-Pertuz, M, Munoz, A (2012) Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst 104: pp. 1897-904 CrossRef
    18. Afzal, S, Bojesen, SE, Nordestgaard, BG (2013) Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem 59: pp. 771-80 CrossRef
    19. Mondul, AM, Weinstein, SJ, Horst, RL, Purdue, M, Albanes, D (2012) Serum vitamin D and risk of bladder cancer in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Cancer Epidemiol Biomarkers Prev 21: pp. 1222-5
文摘
Vitamin D has important biological functions including modulation of the immune system and anti-cancer effects. There was no conclusive finding of the impact of serum vitamin D level on bladder cancer risk. A systemic review and meta-analysis was performed to assess the impact of serum 25-hydroxyvitamin D level on bladder cancer risk. The pooled relative risk (RR) with 95?% confidence interval (95%CI) was used to assess the impact of serum 25-hydroxyvitamin D level on bladder cancer risk. A total of 89,610 participants and 2238 bladder cancer cases were finally included into the meta-analysis. There was no obvious heterogeneity among those included studies (I 2--?%). Meta-analysis total included studies which showed that a high serum 25-hydroxyvitamin D level could obviously decrease risk of bladder cancer (RR--.75, 95%CI 0.65-.87, P--.001). In addition, the pooled RRs were not significantly changed by excluding any single study. The findings from the meta-analysis suggest an obvious protective effect of vitamin D against bladder cancer. Individuals with higher serum 25-hydroxyvitamin D levels suffer from less risk of subsequent bladder cancer.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700